Nuveen Asset Management LLC Buys 99,482 Shares of Semler Scientific, Inc. (NASDAQ:SMLR)

Nuveen Asset Management LLC grew its position in Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) by 396.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 124,548 shares of the company's stock after purchasing an additional 99,482 shares during the period. Nuveen Asset Management LLC owned about 1.34% of Semler Scientific worth $6,726,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. BNP Paribas Financial Markets acquired a new position in Semler Scientific during the 4th quarter valued at about $30,000. Jones Financial Companies Lllp acquired a new stake in shares of Semler Scientific in the 4th quarter valued at approximately $34,000. Larson Financial Group LLC acquired a new stake in shares of Semler Scientific in the 4th quarter valued at approximately $38,000. NewEdge Advisors LLC raised its position in shares of Semler Scientific by 318.3% in the 4th quarter. NewEdge Advisors LLC now owns 732 shares of the company's stock valued at $40,000 after acquiring an additional 557 shares during the period. Finally, IFP Advisors Inc acquired a new stake in shares of Semler Scientific in the 4th quarter valued at approximately $54,000. Institutional investors and hedge funds own 49.37% of the company's stock.

Semler Scientific Price Performance

Semler Scientific stock traded down $0.35 during mid-day trading on Friday, hitting $39.73. 698,780 shares of the company's stock traded hands, compared to its average volume of 490,834. Semler Scientific, Inc. has a fifty-two week low of $21.77 and a fifty-two week high of $81.56. The stock has a market cap of $443.07 million, a price-to-earnings ratio of 8.09 and a beta of 1.33. The firm has a 50 day simple moving average of $36.10 and a two-hundred day simple moving average of $47.00.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last posted its earnings results on Tuesday, May 13th. The company reported ($0.76) earnings per share for the quarter. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%. The firm had revenue of $8.84 million for the quarter.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen cut shares of Semler Scientific from a "buy" rating to a "sell" rating in a research note on Thursday, May 22nd.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.